Option 1: Compounded Retatrutide Retatrutide is not FDA-approved, but research-grade and compounded versions do exist through specific channels
Is glutathione safe during perimenopause
Beyond the contraindication question, hypothyroidism is a common and frequently underdiagnosed condition that causes weight gain, fatigue, and metabolic slowdown symptoms that may be mistakenly attributed to poor GLP-1 response if thyroid dysfunction is not identified and treated
FDA-approved : It is FDA-approved for type 2 diabetes, chronic weight management, and reducing the risk of serious heart problems in adults with obesity or overweight ensuring safety and efficacy for its intended use
Canadian Employer Plans Covering GLP-1s for Weight Loss Have Nearly Doubled Data from the International Foundation of Employee Benefit Plans (IFEBP) 2025 Pulse Survey shows a significant shift in Canadian employer attitudes toward GLP-1 coverage: 31% of employer plans now cover GLP-1s for weight loss (up from 17% in 2024) 56% cover for diabetes only (down from 66% in 2024) 20% of diabetes-only plans are considering adding obesity coverage Provincial public drug plans still cover semaglutide only for type 2 diabetes not for weight loss
What happens if my prescription is not approved